Notify me when Whetstone Capital Advisors, LLC files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| SERA | Sera Prognostics, Inc. | Class A Common Stock, par value $0.0001 per share | 9.2% | $10,218,262 | -$509,945 | 3,459,713 | -4.8% | Whetstone Capital Advisors, LLC | 31 Dec 2025 |
| OPRX | OptimizeRx Corporation | Common Stock, par value $0.001 | 8.2% | $11,689,348 | 1,508,303 | 0% | Whetstone Capital Advisors, LLC | 18 Apr 2025 | |
| HCAT | Health Catalyst, Inc. | Common Stock, par value $0.001 per share | 7.4% | $12,581,618 | +$3,620,092 | 5,265,377 | +40% | Whetstone Capital Advisors, LLC | 15 Jan 2026 |
| BODI | The Beachbody Company, Inc. | Class A Common Stock, par value $0.0001 per share | 6.8% | $2,991,151 | -$571,242 | 297,627 | -16% | Whetstone Capital Advisors, LLC | 31 Dec 2025 |
| LPRO | Open Lending Corporation | Common Stock, par value $0.01 per share | 5.1% | $9,322,734 | 6,014,667 | Whetstone Capital Advisors, LLC | 31 Dec 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|